Publications by authors named "Scott Dickerson"

Claim this Profile
D
Discovery of selective small molecule type III phosphatidylinositol 4-kinase alpha (PI4KIIIα) inhibitors as anti hepatitis C (HCV) agents.
Anna L Leivers, Matthew Tallant, J Brad Shotwell, Scott Dickerson, Martin R Leivers

J Med Chem· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel spiroketal pyrrolidine GSK2336805 potently inhibits key hepatitis C virus genotype 1b mutants: from lead to clinical compound.
Wieslaw M Kazmierski, Andrew Maynard, Maosheng Duan, Sam Baskaran, Janos Botyanszki, Scott Dickerson

J Med Chem· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors.
Tara R Rheault, John C Stellwagen, George M Adjabeng, Keith R Hornberger, Kimberly G Petrov, Scott H Dickerson

ACS Med Chem Lett· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of potent and selective 4-aminothienopyridines as B-Raf kinase inhibitors.
Jun Tang, Karen E Lackey, Scott H Dickerson

Bioorg Med Chem Lett· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations.
James G Greger, Stephen D Eastman, Vivian Zhang, Maureen R Bleam, Ashley M Hughes, Scott H Dickerson

Mol Cancer Ther· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup.
John C Stellwagen, George M Adjabeng, Marc R Arnone, Scott H Dickerson, Chao Han

Bioorg Med Chem Lett· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1.
Curt D Haffner, Stephen A Thomson, Yu Guo, Lee T Schaller, Sharon Boggs, Scott Dickerson

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 ion channel blockers. Part 2.
Curt D Haffner, Stephen A Thomson, Yu Guo, Kimberly Petrov, Andrew Larkin, Scott Dickerson

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.
Alex G Waterson, Kimberly G Petrov, Keith R Hornberger, Robert D Hubbard, Douglas M Sammond, Scott H Dickerson

Bioorg Med Chem Lett· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups.
Steven M Sparks, Pierette Banker, David M Bickett, H Luke Carter, Daphne C Clancy, Scott H Dickerson

Bioorg Med Chem Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues.
Steven M Sparks, Pierette Banker, David M Bickett, Daphne C Clancy, Scott H Dickerson

Bioorg Med Chem Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R).
Kyle A Emmitte, Brian J Wilson, Erich W Baum, Holly K Emerson, Kevin W Kuntz, Scott H Dickerson

Bioorg Med Chem Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors.
Tara R Rheault, Thomas R Caferro, Scott H Dickerson, Kelly H Donaldson, Michael D Gaul

Bioorg Med Chem Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.
Stephen A Thomson, Pierette Banker, D Mark Bickett, Joyce A Boucheron, H Luke Carter, Scott H Dickerson

Bioorg Med Chem Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.
Kirk L Stevens, Krystal J Alligood, Jennifer G Badiang Alberti, Thomas R Caferro, Stanley D Chamberlain, Scott H Dickerson

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual EGFR/ErbB-2 inhibitors from novel pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines.
Robert D Hubbard, Scott H Dickerson, Holly K Emerson, Robert J Griffin, Michael J Reno

Bioorg Med Chem Lett· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge-based design of 7-azaindoles as selective B-Raf inhibitors.
Jun Tang, Toshihiro Hamajima, Masato Nakano, Hideyuki Sato, Scott H Dickerson

Bioorg Med Chem Lett· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases.
Edgar R Wood, Lisa M Shewchuk, Byron Ellis, Perry Brignola, Ronald L Brashear, Scott H Dickerson

Proc Natl Acad Sci U S A· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.
Kimberly G Petrov, Yue-Mei Zhang, Malcolm Carter, G Stuart Cockerill, Scott Dickerson

Bioorg Med Chem Lett· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alkynyl pyrimidines as dual EGFR/ErbB2 kinase inhibitors.
Alex G Waterson, Kirk L Stevens, Michael J Reno, Yue-Mei Zhang, Eric E Boros, Scott H Dickerson

Bioorg Med Chem Lett· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3.
Terrence L Smalley, Andrew J Peat, Joyce A Boucheron, Scott Dickerson, Dulce Garrido

Bioorg Med Chem Lett· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical genomic profiling to identify intracellular targets of a multiplex kinase inhibitor.
Charles Kung, Denise M Kenski, Scott H Dickerson, Russell W Howson, Lee F Kuyper

Proc Natl Acad Sci U S A· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy.
Francis X Tavares, Joyce A Boucheron, Scott H Dickerson, Robert J Griffin, Frank Preugschat

J Med Chem· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells.
Edgar R Wood, Anne T Truesdale, Octerloney B McDonald, Derek Yuan, Anne Hassell, Scott H Dickerson

Cancer Res· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel GSK-3 inhibitors with improved cellular activity.
Andrew J Peat, Dulce Garrido, Joyce A Boucheron, Stephanie L Schweiker, Scott H Dickerson

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis